RICE HALL JAMES & ASSOCIATES, LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14,505,995
-31.7%
696,065
-21.5%
0.92%
-23.6%
Q2 2023$21,230,559
+27.2%
886,453
-0.1%
1.20%
+27.1%
Q1 2023$16,695,711
+9.5%
887,126
-7.4%
0.95%
+8.5%
Q4 2022$15,246,393
+77.9%
957,688
+82.8%
0.87%
+75.9%
Q3 2022$8,571,000
+11.9%
523,870
-3.6%
0.50%
+34.3%
Q2 2022$7,658,000
-31.8%
543,528
+17.3%
0.37%
-17.2%
Q1 2022$11,221,000
+4.3%
463,304
+0.5%
0.45%
+17.0%
Q4 2021$10,761,000
+30.4%
461,051
-7.2%
0.38%
+25.2%
Q3 2021$8,251,000
-34.0%
496,757
-3.1%
0.30%
-31.5%
Q2 2021$12,509,000
-15.5%
512,882
-10.6%
0.44%
-7.9%
Q1 2021$14,808,000
+1.0%
573,936
+109.3%
0.48%
-6.4%
Q4 2020$14,657,000
+29.2%
274,159
-0.3%
0.52%
+12.9%
Q3 2020$11,343,000
+21.9%
274,979
+43.2%
0.46%
+14.5%
Q2 2020$9,304,000
+12.3%
191,958
-2.1%
0.40%
-13.8%
Q1 2020$8,285,000196,0950.46%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders